Your browser doesn't support javascript.
loading
MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients.
Cappuzzo, F; Jänne, P A; Skokan, M; Finocchiaro, G; Rossi, E; Ligorio, C; Zucali, P A; Terracciano, L; Toschi, L; Roncalli, M; Destro, A; Incarbone, M; Alloisio, M; Santoro, A; Varella-Garcia, M.
Affiliation
  • Cappuzzo F; Department of Oncology-Hematology, Istituto Clinico Humanitas IRCCS, Rozzano, Italy. federico.cappuzzo@humanitas.it
Ann Oncol ; 20(2): 298-304, 2009 Feb.
Article in En | MEDLINE | ID: mdl-18836087

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinazolines / Proto-Oncogene Proteins / Receptors, Growth Factor / Carcinoma, Non-Small-Cell Lung / Gene Dosage / Protein Kinase Inhibitors / Lung Neoplasms Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2009 Type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinazolines / Proto-Oncogene Proteins / Receptors, Growth Factor / Carcinoma, Non-Small-Cell Lung / Gene Dosage / Protein Kinase Inhibitors / Lung Neoplasms Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2009 Type: Article Affiliation country: Italy